Skip to main content

and
  1. No Access

    Article

    Tumor-derived interleukin 35 mediates the dissemination of gemcitabine resistance in pancreatic adenocarcinoma

    Rapid development of drug resistance after chemotherapy is a major cause of treatment failure in individuals with pancreatic ductal adenocarcinoma (PDAC). In this study, we illustrate that tumor-derived interl...

    Huizhi Sun, Yi Ge, **g Liu, Zengxun Li, Hui Li, Tiansuo Zhao, **uchao Wang in Oncogene (2024)

  2. Article

    Open Access

    Correction: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

    Chongbiao Huang, Hui Li, Yang Xu, Chao Xu in Signal Transduction and Targeted Therapy (2024)

  3. Article

    Open Access

    BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

    VEGF inhibitors are one of the most successful antiangiogenic drugs in the treatment of many solid tumors. Nevertheless, pancreatic adenocarcinoma (PAAD) cells can reinstate tumor angiogenesis via activation o...

    Chongbiao Huang, Hui Li, Yang Xu, Chao Xu in Signal Transduction and Targeted Therapy (2023)